封面
市場調查報告書
商品編碼
1241832

抗體程序庫技術的全球市場

Antibody Library Technologies

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

抗體程序庫技術的全球市場2030年前將達到2億2,590萬美元

在COVID-19後改變的商務環境中,2022年1億6,460萬美元的抗體程序庫技術的全球市場2030年前將達到2億2,590萬美元的規模,在2022年~2030年預計將以年複合成長率4%增長。本報告所分析之市場區隔之一的噬菌體顯示器年複合成長率將記錄4.3%,到分析期間結束時將達到1億3,310萬美元。考慮疫情後的復甦趨勢,酵母顯示領域今後8年的年複合成長率將修正為4%。

美國市場估算為4,920萬美元,中國則以年複合成長率3.7%的速度成長。

美國的抗體程序庫技術市場在2022年估算為4,920萬美元。作為世界第2大經濟大國的中國,在2022年~2030年年複合成長率預計將為3.7%,2030年達到3,970萬美元的市場規模。其他熱門的地區市場有日本和加拿大,在2022年~2030年預計將各以3.7%和3.3%的速度成長。在歐洲市場中,德國以年複合成長率約4%成長。

調查對像企業範例

  • Abcam PLC
  • AbCheck s.r.o.
  • Abgent, Inc., a WuXi AppTec company
  • Abwiz Bio Inc.
  • Abzena PLC
  • Adimab LLC
  • AnaptysBio, Inc.
  • AvantGen, Inc.
  • Creative-biolabs
  • Dyax Corporation
  • Invenra, Inc.
  • MorphoSys AG
  • Philogen S.p.A.
  • Vaccinex Inc.
  • Xoom Corporation

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP10301

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Antibody Library Technologies Market to Reach $225.9 Million by 2030

In the changed post COVID-19 business landscape, the global market for Antibody Library Technologies estimated at US$164.6 Million in the year 2022, is projected to reach a revised size of US$225.9 Million by 2030, growing at aCAGR of 4% over the period 2022-2030. Phage Display, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$133.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Yeast Display segment is readjusted to a revised 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $49.2 Million, While China is Forecast to Grow at 3.7% CAGR

The Antibody Library Technologies market in the U.S. is estimated at US$49.2 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$39.7 Million by the year 2030 trailing a CAGR of 3.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 47 Featured) -

  • Abcam PLC
  • AbCheck s.r.o.
  • Abgent, Inc., a WuXi AppTec company
  • Abwiz Bio Inc.
  • Abzena PLC
  • Adimab LLC
  • AnaptysBio, Inc.
  • AvantGen, Inc.
  • Creative-biolabs
  • Dyax Corporation
  • Invenra, Inc.
  • MorphoSys AG
  • Philogen S.p.A.
  • Vaccinex Inc.
  • Xoom Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Antibody Library Technologies - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Antibody Library Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Antibody Library Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Antibody Library Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Phage Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Phage Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Phage Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Ribosome Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Ribosome Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Ribosome Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Yeast Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Yeast Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Yeast Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Mammalian Cell Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Mammalian Cell Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Mammalian Cell Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Antibody Library Technologies Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Contract Research Organization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Antibody Library Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Antibody Library Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Antibody Library Technologies by Technology - Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Antibody Library Technologies by Technology - Percentage Breakdown of Value Sales for Phage Display, Yeast Display, Ribosome Display and Mammalian Cell Display for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Antibody Library Technologies by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Antibody Library Technologies by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic & Research Institutes for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Antibody Library Technologies by Application - Drug Discovery & Development, Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Antibody Library Technologies by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Research and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION